These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10967105)

  • 1. BAG1L enhances trans-activation function of the vitamin D receptor.
    Guzey M; Takayama S; Reed JC
    J Biol Chem; 2000 Dec; 275(52):40749-56. PubMed ID: 10967105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function analysis of Bag1 proteins. Effects on androgen receptor transcriptional activity.
    Knee DA; Froesch BA; Nuber U; Takayama S; Reed JC
    J Biol Chem; 2001 Apr; 276(16):12718-24. PubMed ID: 11278763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
    Ward JO; McConnell MJ; Carlile GW; Pandolfi PP; Licht JD; Freedman LP
    Blood; 2001 Dec; 98(12):3290-300. PubMed ID: 11719366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
    Zhuang SH; Burnstein KL
    Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1).
    Castillo AI; Jimenez-Lara AM; Tolon RM; Aranda A
    Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M; Carlberg C
    J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bag1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells.
    Kudoh M; Knee DA; Takayama S; Reed JC
    Cancer Res; 2002 Mar; 62(6):1904-9. PubMed ID: 11912172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.
    Saramäki A; Banwell CM; Campbell MJ; Carlberg C
    Nucleic Acids Res; 2006; 34(2):543-54. PubMed ID: 16434701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic studies to evaluate the enhanced antiproliferation of human keratinocytes by 1alpha,25-dihydroxyvitamin D(3)-3-bromoacetate, a covalent modifier of vitamin D receptor, compared to 1alpha,25-dihydroxyvitamin D(3).
    Chen ML; Ray S; Swamy N; Holick MF; Ray R
    Arch Biochem Biophys; 1999 Oct; 370(1):34-44. PubMed ID: 10496974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of chromatin organization of vitamin D target genes.
    Carlberg C; Dunlop TW
    Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the human vitamin D receptor by caspase-3.
    Malloy PJ; Feldman D
    Endocrinology; 2009 Feb; 150(2):679-86. PubMed ID: 18832097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM; Bishop JE; Ishizuka S; Norman AW
    Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling.
    Hsieh JC; Sisk JM; Jurutka PW; Haussler CA; Slater SA; Haussler MR; Thompson CC
    J Biol Chem; 2003 Oct; 278(40):38665-74. PubMed ID: 12847098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the molecular mechanism for the antagonistic action of a novel 1alpha,25-dihydroxyvitamin D(3) analogue toward vitamin D receptor function.
    Ozono K; Saito M; Miura D; Michigami T; Nakajima S; Ishizuka S
    J Biol Chem; 1999 Nov; 274(45):32376-81. PubMed ID: 10542279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions.
    Norman AW; Manchand PS; Uskokovic MR; Okamura WH; Takeuchi JA; Bishop JE; Hisatake JI; Koeffler HP; Peleg S
    J Med Chem; 2000 Jul; 43(14):2719-30. PubMed ID: 10893309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.